BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29544756)

  • 1. Cervical Lymph Node Metastatic Status and Adjuvant Therapy Predict the Prognosis of Salivary Duct Carcinoma.
    Qian K; Di L; Guo K; Zheng X; Ji Q; Wang Z
    J Oral Maxillofac Surg; 2018 Jul; 76(7):1578-1586. PubMed ID: 29544756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher positive lymph node ratio indicates poorer distant metastasis-free survival in adenoid cystic carcinoma patients with nodal involvement.
    Liu Z; Fang Z; Dai T; Zhang C; Sun J; He Y
    J Craniomaxillofac Surg; 2015 Jul; 43(6):751-7. PubMed ID: 25958766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
    Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A
    Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
    Boon E; Bel M; van Boxtel W; van der Graaf WTA; van Es RJJ; Eerenstein SEJ; Baatenburg de Jong RJ; van den Brekel MWM; van der Velden LA; Witjes MJH; Hoeben A; Willems SM; Bloemena E; Smit LA; Oosting SF; ; Jonker MA; Flucke UE; van Herpen CML
    Int J Cancer; 2018 Aug; 143(4):758-766. PubMed ID: 29492965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of adjuvant therapy on the prognosis of ductal carcinoma of the major salivary gland: a large-scale cohort study.
    Zhang D; Li L; Wen T; Ma F
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):409-417. PubMed ID: 36036273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of lymph node density in high-grade salivary gland cancers.
    Hong HR; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2015 May; 111(6):784-9. PubMed ID: 25640975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High metastatic node number, not extranodal extension, as a node-related prognosticator in surgically treated patients with nodal metastatic salivary gland carcinoma.
    Hsieh CE; Hung CY; Lin CY; Chen JS; Chang KP; Aithala SP; Lee LY; Tsang NM; Lu CH; Chen MF; Cheng YF; Yeh KY; Wang CH; Chou WC
    Head Neck; 2019 Jun; 41(6):1572-1582. PubMed ID: 30652371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parotid salivary duct carcinoma: a single institution's 20-year experience.
    Stodulski D; Mikaszewski B; Majewska H; Kuczkowski J
    Eur Arch Otorhinolaryngol; 2019 Jul; 276(7):2031-2038. PubMed ID: 31062093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.
    Jayaprakash V; Merzianu M; Warren GW; Arshad H; Hicks WL; Rigual NR; Sullivan MA; Seshadri M; Marshall JR; Cohan DM; Zhao Y; Singh AK
    Head Neck; 2014 May; 36(5):694-701. PubMed ID: 23606370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and outcome of patients with malignant salivary gland tumors.
    Bell RB; Dierks EJ; Homer L; Potter BE
    J Oral Maxillofac Surg; 2005 Jul; 63(7):917-28. PubMed ID: 16003616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glands.
    Kim JY; Lee S; Cho KJ; Kim SY; Nam SY; Choi SH; Roh JL; Choi EK; Kim JH; Song SY; Shin HS; Chang SK; Ahn SD
    Br J Radiol; 2012 Oct; 85(1018):e947-52. PubMed ID: 22573301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
    Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
    Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of 52 cases of adenoid cystic carcinoma in minor salivary gland].
    Wang JF; Ge MH; Wang KJ; Tan Z; Chen C; Xu JJ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Dec; 47(12):705-10. PubMed ID: 23328093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior cervical lymph node metastasis as the valuable prognostic factor for stage IVA/IVB nasopharyngeal carcinoma treated with induction chemotherapy followed by concurrent chemo-radiotherapy.
    Thephamongkhol K; Setakornnukul J; Rojwatkarnjana S; Chansilpa Y
    Int J Biol Markers; 2014 Dec; 29(4):e387-94. PubMed ID: 25198554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases?
    Gruber G; Berclaz G; Altermatt HJ; Greiner RH
    Strahlenther Onkol; 2003 Oct; 179(10):661-6. PubMed ID: 14566473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx.
    Ai QY; King AD; Poon DMC; Mo FKF; Hui EP; Tong M; Ahuja AT; Ma BBY; Chan ATC
    Oral Oncol; 2019 Jan; 88():124-130. PubMed ID: 30616782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
    Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.